Caption Management, LLC Verastem, Inc. Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$2.57 - $4.85 $128,499 - $242,499	-50,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.9 - $2.82 $95,000 - $141,000	50,000 New	50,000 $123,000
Q4 2018 Jan 30, 2019	SELL	$3.23 - $7.01 $19,380 - $42,060	-6,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$6.86 - $9.97 $41,160 - $59,820	6,000 New	6,000 $44,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.